274 related articles for article (PubMed ID: 10495430)
1. Cancer gene therapy with HSV-tk/GCV system depends on T-cell-mediated immune responses and causes apoptotic death of tumor cells in vivo.
Kuriyama S; Kikukawa M; Masui K; Okuda H; Nakatani T; Akahane T; Mitoro A; Tominaga K; Tsujinoue H; Yoshiji H; Okamoto S; Fukui H; Ikenaka K
Int J Cancer; 1999 Oct; 83(3):374-80. PubMed ID: 10495430
[TBL] [Abstract][Full Text] [Related]
2. Comparison of gene therapy with the herpes simplex virus thymidine kinase gene and the bacterial cytosine deaminase gene for the treatment of hepatocellular carcinoma.
Kuriyama S; Mitoro A; Yamazaki M; Tsujinoue H; Nakatani T; Akahane T; Toyokawa Y; Kojima H; Okamoto S; Fukui H
Scand J Gastroenterol; 1999 Oct; 34(10):1033-41. PubMed ID: 10563675
[TBL] [Abstract][Full Text] [Related]
3. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer.
Tang Q; Zhang D; Wan M; Jin L
Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766
[TBL] [Abstract][Full Text] [Related]
4. Adeno-associated viral-mediated gene transfer to hepatoma: thymidine kinase/interleukin 2 is more effective in tumor killing in non-ganciclovir (GCV)-treated than in GCV-treated animals.
Su H; Lu R; Ding R; Kan YW
Mol Ther; 2000 Jun; 1(6):509-15. PubMed ID: 10933975
[TBL] [Abstract][Full Text] [Related]
5. Enhanced anti-tumor effects of herpes simplex virus thymidine kinase/ganciclovir system by codelivering monocyte chemoattractant protein-1 in hepatocellular carcinoma.
Sakai Y; Kaneko S; Nakamoto Y; Kagaya T; Mukaida N; Kobayashi K
Cancer Gene Ther; 2001 Oct; 8(10):695-704. PubMed ID: 11687892
[TBL] [Abstract][Full Text] [Related]
6. Retrovirus-mediated herpes simplex virus thymidine kinase gene transduction renders human thyroid carcinoma cell lines sensitive to ganciclovir and radiation in vitro and in vivo.
Nishihara E; Nagayama Y; Mawatari F; Tanaka K; Namba H; Niwa M; Yamashita S
Endocrinology; 1997 Nov; 138(11):4577-83. PubMed ID: 9348181
[TBL] [Abstract][Full Text] [Related]
7. [Effects of retrovirus-mediated HSV-tk/GCV on human hepatocellular carcinoma].
Zhao Y; Zhang X; Hui H
Zhonghua Gan Zang Bing Za Zhi; 1999 Jun; 7(2):113-5. PubMed ID: 10488424
[TBL] [Abstract][Full Text] [Related]
8. Tissue-specific expression of HSV-tk gene can induce efficient antitumor effect and protective immunity to wild-type hepatocellular carcinoma.
Kuriyama S; Sakamoto T; Masui K; Nakatani T; Tominaga K; Kikukawa M; Yoshikawa M; Ikenaka K; Fukui H; Tsujii T
Int J Cancer; 1997 May; 71(3):470-5. PubMed ID: 9139886
[TBL] [Abstract][Full Text] [Related]
9. Intravenous RMP-7 increases delivery of ganciclovir into rat brain tumors and enhances the effects of herpes simplex virus thymidine kinase gene therapy.
LeMay DR; Kittaka M; Gordon EM; Gray B; Stins MF; McComb JG; Jovanovic S; Tabrizi P; Weiss MH; Bartus R; Anderson WF; Zlokovic BV
Hum Gene Ther; 1998 May; 9(7):989-95. PubMed ID: 9607410
[TBL] [Abstract][Full Text] [Related]
10. Temozolomide enhances herpes simplex virus thymidine kinase/ganciclovir therapy of malignant glioma.
Rainov NG; Fels C; Droege JW; Schäfer C; Kramm CM; Chou TC
Cancer Gene Ther; 2001 Sep; 8(9):662-8. PubMed ID: 11593335
[TBL] [Abstract][Full Text] [Related]
11. Enhanced therapeutic effect of multiple injections of HSV-TK + GCV gene therapy in combination with ionizing radiation in a mouse mammary tumor model.
Vlachaki MT; Chhikara M; Aguilar L; Zhu X; Chiu KJ; Woo S; Teh BS; Thompson TC; Butler EB; Aguilar-Cordova E
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1008-17. PubMed ID: 11704325
[TBL] [Abstract][Full Text] [Related]
12. Expression of costimulatory molecules: B7 and ICAM up-regulation after treatment with a suicide gene.
Ramesh R; Munshi A; Abboud CN; Marrogi AJ; Freeman SM
Cancer Gene Ther; 1996; 3(6):373-84. PubMed ID: 8988840
[TBL] [Abstract][Full Text] [Related]
13. In vivo antitumor effect of herpes simplex virus thymidine kinase gene therapy in rat hepatocellular carcinoma: feasibility of adenovirus-mediated intra-arterial gene delivery.
Kwon HC; Kim JH; Kim KC; Lee KH; Lee JH; Lee BH; Lee KH; Jang JJ; Lee CT; Lee H; Kim CM
Mol Cells; 2001 Apr; 11(2):170-8. PubMed ID: 11355697
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of herpes simplex thymidine kinase mediated gene therapy in experimental pancreatic cancer.
Mäkinen K; Loimas S; Wahlfors J; Alhava E; Jänne J
J Gene Med; 2000; 2(5):361-7. PubMed ID: 11045430
[TBL] [Abstract][Full Text] [Related]
15. Synergy between the herpes simplex virus tk/ganciclovir prodrug suicide system and the topoisomerase I inhibitor topotecan.
Wildner O; Blaese RM; Morris JC
Hum Gene Ther; 1999 Nov; 10(16):2679-87. PubMed ID: 10566896
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene.
Yang L; Hwang R; Chiang Y; Gordon EM; Anderson WF; Parekh D
Clin Cancer Res; 1998 Mar; 4(3):731-41. PubMed ID: 9533543
[TBL] [Abstract][Full Text] [Related]
17. Non-Small-Cell Lung Cancer: Feasibility of Intratumoral Radiofrequency Hyperthermia-enhanced Herpes Simplex Virus Thymidine Kinase Gene Therapy.
Ji J; Weng Q; Zhang F; Xiong F; Jin Y; Hui J; Song J; Gao J; Chen M; Li Q; Shin D; Yang X
Radiology; 2018 Aug; 288(2):612-620. PubMed ID: 29893649
[TBL] [Abstract][Full Text] [Related]
18. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 2. Tumor-specific immunity and cure after radio-inducible suicide gene therapy and systemic CD40-ligand and Flt3-ligand gene therapy in an orthotopic tumor model.
Kawashita Y; Deb NJ; Garg MK; Kabarriti R; Fan Z; Alfieri AA; Roy-Chowdhury J; Guha C
Radiat Res; 2014 Aug; 182(2):201-10. PubMed ID: 24992166
[TBL] [Abstract][Full Text] [Related]
19. Limitations of retrovirus-mediated HSV-tk gene transfer to pulmonary adenocarcinoma cells in vitro and in vivo.
Zhang L; Wikenheiser KA; Whitsett JA
Hum Gene Ther; 1997 Mar; 8(5):563-74. PubMed ID: 9095408
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of tumor killing using a combination of tumor immunization and HSV-tk suicide gene therapy.
Ramesh R; Munshi A; Marrogi AJ; Freeman SM
Int J Cancer; 1999 Jan; 80(3):380-6. PubMed ID: 9935178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
